Optimal management of a patient with recurrent nasopharyngeal carcinoma
CNR Ibb | back to homepage
CNR Ibb | back to homepage

Optimal management of a patient with recurrent nasopharyngeal carcinoma (342 views)

Perri F, Dell'Oca I, Muto P, Schiavone C, Aversa C, Fulciniti F, Solla R, Scarpati GD, Buonerba C, Di Lorenzo G, Caponigro F

World Journal Of Clinical Cases (ISSN: 2307-8960), 2014; 2(7): 297-300.

Export to BibTeX    Export to EndNote

Paper type: Journal Article,

Impact factor: 0.895, 5-year impact factor: 1.273

Url: Not available.

Keywords: Cetuximab, Nasopharyngeal Carcinoma, Re-Irradiation, Surgery Of Metastases, Undifferentiated,

Affiliations:
*** IBB - CNR ***

Francesco Perri, Francesco Caponigro, Head and Neck Medical Oncology Unit, National Tumor Institute of Naples, 80131 Naples, Italy.


References:
Not available.
Optimal management of a patient with recurrent nasopharyngeal carcinoma

Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed, non-metastatic disease, management of recurrent disease is challenging, with a survival expectancy of approximately 6 mo with the use of chemotherapy as the sole salvage treatment. We report a case of recurrent nasopharyngeal carcinoma treated with a combination of chemotherapy, radiotherapy and surgery in the context of a multidisciplinary approach. A durable complete response was achieved.
Optimal management of a patient with recurrent nasopharyngeal carcinoma

No results.
Optimal management of a patient with recurrent nasopharyngeal carcinoma

Filter those results▼
Query:  [X]
Options:
   Extended  
   IBB affiliation
 
Authors:  [X]
Paper type:  [X]
Start date:  [X]
End date:  [X]
Site:
[Clear form]
Select the year: 
Other filter: ([btitle,keywords] "Nasopharyngeal Carci ...

Sort by:   date ▼▲   title ▲ ▼   journal ▲ ▼   authors ▲ ▼   I.F. ▲ ▼
Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R
* Management of recurrent nasopharyngeal carcinoma: current perspectives (239 views)
Oncotargets Ther (ISSN: 1178-6930linking), 2019 Feb 26; 12: 1583-1591.
Impact Factor: 2.272
View    Export to BibTeX    Export to EndNote

Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (637 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
View    Export to BibTeX    Export to EndNote

2 Records (2 excluding Abstracts).
Total impact factor: 7.308 (7.308 excluding Abstracts).
Total 5 year impact factor: 6.9 (6.9 excluding Abstracts).

Last modified by Raffaele Berisio  on Sunday 12 July 2020, 13:14:52
342 views. Last view on Tuesday 10 September 2024, 16:56:56